Amrit Ray's most recent trade in Fortrea Holdings Inc was a trade of 38,817 Restricted Stock Unit done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fortrea Holdings Inc | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 38,817 | 38,817 | - | - | Restricted Stock Unit | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 10,787 | 10,787 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,740 | 23,365 (0%) | 0% | 0 | Common Stock | |
| Fortrea Holdings Inc | Amrit Ray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 7,282 | 0 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Amrit Ray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 7,282 | 13,636 | - | 0 | Common Stock | |
| Fortrea Holdings Inc | Amrit Ray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2024 | 6,354 | 6,354 | - | 0 | Common Stock | |
| Fortrea Holdings Inc | Amrit Ray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2024 | 6,354 | 7,282 | - | - | Restricted Stock Unit | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 9,900 | 9,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 5,345 | 17,625 (0%) | 0% | 0 | Common Stock | |
| Fortrea Holdings Inc | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 7,282 | 13,636 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 6,354 | 6,354 | - | - | Restricted Stock Unit | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 7,110 | 7,110 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,860 | 12,280 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,245 | 6,245 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 3,300 | 8,420 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 9,525 | 9,525 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Amrit Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 5,120 | 5,120 (0%) | 0% | 0 | Common Stock |